Metraipolis › archive › dc_2fae790ea324

Comparative Risk of Complications Following Intestinal Surgery After Infliximab, Vedolizumab, or Ustekinumab Treatment: Systematic Review & Meta-Analysis — Europe PMC PMID:41155581

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41155581
DOI: 10.3390/ph18101466
License (as archived): solo-consultazione
Archived: 2026-11-09T17:17:51.407Z
SHA-256 of the archived text: 8944db126c6b7e3e8222a73a6948bb3afcd0e7b1c68d9e88ca1318a045a42b12
Stable URL of this page: https://metraipolis.com/documento/dc_2fae790ea324

How to cite

Comparative Risk of Complications Following Intestinal Surgery After Infliximab, Vedolizumab, or Ustekinumab Treatment: Systematic Review & Meta-Analysis — Europe PMC PMID:41155581 — Europe PMC (en), https://europepmc.org/article/MED/41155581 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2fae790ea324 (Metraipolis archive dc_2fae790ea324, sha256 8944db126c6b7e3e8222a73a6948bb3afcd0e7b1c68d9e88ca1318a045a42b12)

BibTeX

@misc{dc2fae790ea324,
  title = {Comparative Risk of Complications Following Intestinal Surgery After Infliximab, Vedolizumab, or Ustekinumab Treatment: Systematic Review & Meta-Analysis — Europe PMC PMID:41155581},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41155581},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2fae790ea324; sha256 8944db126c6b7e3e8222a73a6948bb3afcd0e7b1c68d9e88ca1318a045a42b12},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41155581. Agents can read the archived copy with the MCP tool read_document.